Convergence Investment Partners LLC Invests $2.58 Million in Cardinal Health, Inc. (CAH) Stock

Convergence Investment Partners LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 38,602 shares of the company’s stock, valued at approximately $2,583,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bronfman E.L. Rothschild L.P. increased its holdings in Cardinal Health by 31.8% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after buying an additional 382 shares during the last quarter. Advisory Services Network LLC increased its holdings in Cardinal Health by 18.4% during the second quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock worth $136,000 after buying an additional 270 shares during the last quarter. Dupont Capital Management Corp acquired a new position in Cardinal Health during the second quarter worth $164,000. First Personal Financial Services increased its holdings in Cardinal Health by 127.5% during the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after buying an additional 1,238 shares during the last quarter. Finally, Sun Life Financial INC increased its holdings in Cardinal Health by 16,228.6% during the second quarter. Sun Life Financial INC now owns 2,286 shares of the company’s stock worth $178,000 after buying an additional 2,272 shares during the last quarter. Institutional investors and hedge funds own 88.47% of the company’s stock.

Cardinal Health, Inc. (NYSE:CAH) opened at $61.02 on Tuesday. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.06 and a quick ratio of 0.52. Cardinal Health, Inc. has a fifty-two week low of $54.66 and a fifty-two week high of $84.88. The company has a market cap of $19,230.00, a price-to-earnings ratio of 11.18, a price-to-earnings-growth ratio of 1.70 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Monday, November 6th. The company reported $1.09 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.00 by $0.09. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The business had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $33.48 billion. During the same period in the prior year, the company posted $1.24 earnings per share. Cardinal Health’s revenue was up 1.9% compared to the same quarter last year. equities research analysts predict that Cardinal Health, Inc. will post 4.97 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be paid a $0.4624 dividend. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.85 annualized dividend and a dividend yield of 3.03%. Cardinal Health’s dividend payout ratio (DPR) is presently 53.94%.

A number of brokerages recently weighed in on CAH. UBS restated a “neutral” rating and set a $76.00 target price (down from $79.00) on shares of Cardinal Health in a report on Wednesday, August 9th. Deutsche Bank began coverage on shares of Cardinal Health in a report on Monday. They set a “hold” rating and a $64.00 target price on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Cardinal Health in a report on Thursday, October 12th. Zacks Investment Research downgraded shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Monday, August 7th. Finally, Jefferies Group decreased their price objective on shares of Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have issued a buy rating to the company. Cardinal Health currently has an average rating of “Hold” and an average price target of $73.91.

TRADEMARK VIOLATION WARNING: This report was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.chaffeybreeze.com/2017/12/05/convergence-investment-partners-llc-invests-2-58-million-in-cardinal-health-inc-cah-stock.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply